Wheat Beer for Prevention of Delirium in Intensive Care Patients
Recruiting now · Not applicable
Conditions studied: ICU Delirium
In brief
The investigators hypothesise that the daily administration of 0.5L alcohol-containing wheat beer at 8 pm over a study period of 6 days in a row leads to a lower prevalence of delirium compared to water following the same administration scheme.
Key facts
- Study ID
- NCT04876742
- Run by
- University Hospital, Basel, Switzerland
- People needed
- 380
- Starts
- 2023-01-18
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2026-06-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All Patients meeting the following criteria are eligible for the study:
- Risk of delirium: ICU patients with expected length of stay (LOS) ≥ 24 hours
- Naso-gastric tube in situ
- ICU stay ≤ 72h until first study intervention
- Women: negative pregnancy test, age ≥50 years or status post hysterectomy/bilateral ovariectomy
- Adult patients (age ≥ 18 years)
- ≥ 50 kg body weight or BMI ≥18.5
You may not qualify if…
- Patients fulfilling the following criteria are excluded from the study:
- Pre-existing liver pathologies
- Patients after bone marrow transplantation
- Women: breastfeeding
- Pre-existing delirium (ICDSC ≥ 4)
- Terminal state
- Active psychosis
- Anamnestic complete alcohol abstinence or status post alcohol abuse
- Especially vulnerable patients
- Allergy to any ingredient(s) of beer
Where it is running
- University Hospital Basel — Basel, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.